Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Type iia hyperlipidaemia: Which Medications Cause It? (202 Reports Across 15 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Type iia hyperlipidaemia has been reported as an adverse event with 15 different drugs in the FDA's FAERS database, with 202 total reports. 61 of these reports resulted in death.The drugs most commonly associated with Type iia hyperlipidaemia are ATORVASTATIN, EZETIMIBE, and EVOLOCUMAB.

202
Total Reports
15
Drugs Involved
61
Deaths
57
Hospitalizations
61.0 yrs
Average Patient Age
50.3% / 49.7%
Female / Male

Which Drugs Cause Type iia hyperlipidaemia Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
ATORVASTATIN 67 0.1% 54 15 0
EZETIMIBE 67 0.5% 55 14 0
EVOLOCUMAB 66 0.0% 55 14 1
ROSUVASTATIN 63 0.2% 54 14 0
SIMVASTATIN 63 0.2% 55 13 0
LOMITAPIDE 59 1.6% 55 13 0
LOVASTATIN 56 4.0% 55 12 0
PROBUCOL 56 35.7% 55 12 0
IMPLITAPIDE 49 98.0% 49 10 0
CAFFEINE\PROCAINE 10 100.0% 10 7 0
TOCILIZUMAB 8 0.0% 0 2 0
ADALIMUMAB 7 0.0% 0 4 0
ALIROCUMAB 6 0.0% 0 2 0
CHOLECALCIFEROL 5 0.0% 0 2 0
SACUBITRIL\VALSARTAN 5 0.0% 0 3 0

View all 15 drugs →

Top 3 Drugs Associated With Type iia hyperlipidaemia

67 reports
67 reports
66 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)